{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:59:18Z","timestamp":1792094358324,"version":"4.4.0"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,30]]},"DOI":"10.18632\/oncotarget.10927","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T16:24:03Z","timestamp":1469809443000},"page":"56976-56985","source":"Crossref","is-referenced-by-count":22,"title":["Telomere status in chronic lymphocytic leukemia with <i>TP53<\/i> disruption"],"prefix":"10.18632","volume":"7","author":[{"given":"Romain","family":"Gui\u00e8ze","sequence":"first","affiliation":[{"name":"CHU Clermont-Ferrand, H\u00e9matologie Clinique, Clermont-Ferrand, France"},{"name":"EA 7283 CREaT, Universit\u00e9 d\u2019Auvergne, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Pages","sequence":"additional","affiliation":[{"name":"Department de Neuropathologie, H\u00f4pital Sainte-Anne, Paris, France"},{"name":"Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"V\u00e9ron\u00e8se","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Clermont 1, UFR M\u00e9decine, Cytologie Histologie Embryologie Cytog\u00e9n\u00e9tique, Clermont-Ferrand, France"},{"name":"CHU Clermont-Ferrand, Cytog\u00e9n\u00e9tique M\u00e9dicale, Clermont-Ferrand, France"},{"name":"EA 4677 ERTICa, Universit\u00e9 d\u2019Auvergne, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Combes","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Clermont 1, UFR M\u00e9decine, Cytologie Histologie Embryologie Cytog\u00e9n\u00e9tique, Clermont-Ferrand, France"},{"name":"CHU Clermont-Ferrand, Cytog\u00e9n\u00e9tique M\u00e9dicale, Clermont-Ferrand, France"},{"name":"EA 4677 ERTICa, Universit\u00e9 d\u2019Auvergne, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lemal","sequence":"additional","affiliation":[{"name":"CHU Clermont-Ferrand, H\u00e9matologie Clinique, Clermont-Ferrand, France"},{"name":"EA 7283 CREaT, Universit\u00e9 d\u2019Auvergne, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Gay-bellile","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Clermont 1, UFR M\u00e9decine, Cytologie Histologie Embryologie Cytog\u00e9n\u00e9tique, Clermont-Ferrand, France"},{"name":"CHU Clermont-Ferrand, Cytog\u00e9n\u00e9tique M\u00e9dicale, Clermont-Ferrand, France"},{"name":"EA 4677 ERTICa, Universit\u00e9 d\u2019Auvergne, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Chauvet","sequence":"additional","affiliation":[{"name":"Inserm U823, Institut Albert Bonniot & Universit\u00e9 Joseph Fourier, Grenoble, France"},{"name":"CHU Grenoble, Laboratoire de G\u00e9n\u00e9tique Onco-h\u00e9matologique, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Callanan","sequence":"additional","affiliation":[{"name":"Inserm U823, Institut Albert Bonniot & Universit\u00e9 Joseph Fourier, Grenoble, France"},{"name":"CHU Grenoble, Laboratoire de G\u00e9n\u00e9tique Onco-h\u00e9matologique, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Kwiatkowski","sequence":"additional","affiliation":[{"name":"EA 4677 ERTICa, Universit\u00e9 d\u2019Auvergne, Clermont-Ferrand, France"},{"name":"Centre Jean Perrin, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[{"name":"Direction de la Recherche Clinique et de l\u2019Innovation, D\u00e9partement de Biostatistiques, CHU Clermont-Ferrand, Clermont Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vago","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Clermont 1, UFR M\u00e9decine, Cytologie Histologie Embryologie Cytog\u00e9n\u00e9tique, Clermont-Ferrand, France"},{"name":"CHU Clermont-Ferrand, Cytog\u00e9n\u00e9tique M\u00e9dicale, Clermont-Ferrand, France"},{"name":"EA 4677 ERTICa, Universit\u00e9 d\u2019Auvergne, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Olivier","family":"Bay","sequence":"additional","affiliation":[{"name":"CHU Clermont-Ferrand, H\u00e9matologie Clinique, Clermont-Ferrand, France"},{"name":"EA 7283 CREaT, Universit\u00e9 d\u2019Auvergne, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tournilhac","sequence":"additional","affiliation":[{"name":"CHU Clermont-Ferrand, H\u00e9matologie Clinique, Clermont-Ferrand, France"},{"name":"EA 7283 CREaT, Universit\u00e9 d\u2019Auvergne, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre\u00ef","family":"Tchirkov","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Clermont 1, UFR M\u00e9decine, Cytologie Histologie Embryologie Cytog\u00e9n\u00e9tique, Clermont-Ferrand, France"},{"name":"CHU Clermont-Ferrand, Cytog\u00e9n\u00e9tique M\u00e9dicale, Clermont-Ferrand, France"},{"name":"EA 4677 ERTICa, Universit\u00e9 d\u2019Auvergne, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1101\/gad.1346005","article-title":"Shelterin: the protein complex that shapes and safeguards human telomeres","volume":"19","author":"de Lange","year":"2005","journal-title":"Genes Dev"},{"key":"2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc3025","article-title":"Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins","volume":"11","author":"Blasco","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0092-8674(00)80762-X","article-title":"p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis","volume":"97","author":"DePinho","year":"1999","journal-title":"Cell"},{"key":"4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/35020592","article-title":"Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice","volume":"406","author":"DePinho","year":"2000","journal-title":"Nature"},{"key":"5","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1038\/sj.onc.1209486","article-title":"Telomere dysfunction and loss of p53 cooperate in defective mitotic segregation of chromosomes in cancer cells","volume":"25","author":"Martens","year":"2006","journal-title":"Oncogene"},{"key":"6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2003-04-1345","article-title":"Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations","volume":"103","author":"Ferrarini","year":"2004","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/annonc\/mdh389","article-title":"hTERT expression and prognosis in B-chronic lymphocytic leukemia","volume":"15","author":"Travade","year":"2004","journal-title":"Ann Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.leu.2404607","article-title":"Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome","volume":"21","author":"De Rossi","year":"2007","journal-title":"Leukemia"},{"key":"9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bjh.13023","article-title":"Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease","volume":"167","author":"Fegan","year":"2014","journal-title":"Br J Haematol"},{"key":"10","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/leu.2015.217","article-title":"Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial","volume":"29","author":"Steele","year":"2015","journal-title":"Leukemia"},{"key":"11","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1182\/blood-2007-09-111245","article-title":"Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia","volume":"111","author":"Gilson","year":"2008","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/gcc.22171","article-title":"Relevance of telomere\/telomerase system impairment in early stage chronic lymphocytic leukemia","volume":"53","author":"Neri","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"13","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2010-07-295774","article-title":"Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation","volume":"118","author":"Poncet","year":"2011","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood-2007-05-092759","article-title":"Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia","volume":"111","author":"Stilgenbauer","year":"2008","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/leu.2012.194","article-title":"Telomeres and chromosomal instability in chronic lymphocytic leukemia","volume":"27","author":"Bay","year":"2013","journal-title":"Leukemia"},{"key":"16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ajh.23466","article-title":"Short telomere length is associated with NOTCH1\/SF3B1\/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients","volume":"88","author":"Rosenquist","year":"2013","journal-title":"Am J Hematol"},{"key":"17","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1200\/JCO.2009.27.8762","article-title":"TP53 mutation and survival in chronic lymphocytic leukemia","volume":"28","author":"D\u00f6hner","year":"2010","journal-title":"J Clin Oncol"},{"key":"18","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1200\/JCO.2010.32.0838","article-title":"Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial","volume":"29","author":"Morgan","year":"2011","journal-title":"J Clin Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3324\/haematol.2011.049874","article-title":"Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes","volume":"97","author":"De Rossi","year":"2012","journal-title":"Haematologica"},{"key":"20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1078-0432.CCR-08-1630","article-title":"The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness","volume":"15","author":"Gaidano","year":"2009","journal-title":"Clin Cancer Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1038\/sj.onc.1203890","article-title":"Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells","volume":"19","author":"Pisa","year":"2000","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/carcin\/bgp268","article-title":"Telomeres and telomerase in cancer","volume":"31","author":"DePinho","year":"2010","journal-title":"Carcinogenesis"},{"key":"23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng.2584","article-title":"POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia","volume":"45","author":"Puente","year":"2013","journal-title":"Nat Genet"},{"key":"24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-014-2975-x","article-title":"The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines","volume":"145","author":"Roberts","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Mertens","year":"2015","journal-title":"Nature"},{"key":"26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/asheducation-2011.1.480","article-title":"Dyskeratosis congenita","volume":"2011","author":"Dokal","year":"2011","journal-title":"Hematol Educ Program Am Soc Hematol Am Soc Hematol Educ Program"},{"key":"27","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1182\/blood-2014-08-596445","article-title":"Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1","volume":"124","author":"Christodoulou","year":"2014","journal-title":"Blood"},{"key":"28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/leu.2011.281","article-title":"Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage","volume":"26","author":"Baird","year":"2012","journal-title":"Leukemia"},{"key":"29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/nucl.2.2.15135","article-title":"Shelterin complex and associated factors at human telomeres","volume":"2","author":"Loayza","year":"2011","journal-title":"Nucleus"},{"key":"30","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1182\/blood.V126.23.2906.2906","article-title":"Comprehensive bulk and single cell transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia","volume":"126","author":"Wu","year":"2015","journal-title":"Blood"},{"key":"31","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1182\/blood-2015-05-647578","article-title":"Presence of multiple recurrent mutations confers poor trial outcome of relapsed\/refractory CLL","volume":"126","author":"V\u00e9ron\u00e8se","year":"2015","journal-title":"Blood"},{"key":"32","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Kipps","year":"2008","journal-title":"Blood"},{"key":"33","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","article-title":"Telomere measurement by quantitative PCR","volume":"30","author":"Cawthon","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"34","first-page":"715","article-title":"Sem: a suitable statistical software adaptated for research in oncology","volume":"87","author":"Berlie","year":"2000","journal-title":"Bull Cancer"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10927","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:20:19Z","timestamp":1594830019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":34,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2016,8,30]]}},"alternative-id":["10927","27486974"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10927","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]}}}